KEAP1 and hepatocellular carcinoma: The research of Zhao et al. shows that ubiquitin protein ligase E3 component N-recognin 7 (UBR7) activates the Keap1/Nrf2/Bach1/HK2 axis to reduce the content of HK2 in hepatoma cells and inhibit the glycolysis and proliferation of hepatoma cells.